Elite Pharmaceuticals Inc (ELTP)
0.5101
+0.01
(+1.75%)
USD |
OTCM |
Nov 04, 15:59
Elite Pharmaceuticals Debt to Equity Ratio: 0.1317 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1317 |
| March 31, 2024 | 0.1316 |
| December 31, 2023 | 0.1642 |
| September 30, 2023 | 0.1696 |
| June 30, 2023 | 0.26 |
| March 31, 2023 | 0.1337 |
| December 31, 2022 | 0.5289 |
| September 30, 2022 | 0.5897 |
| June 30, 2022 | 0.5343 |
| March 31, 2022 | 0.0691 |
| December 31, 2021 | 0.0805 |
| September 30, 2021 | 0.0968 |
| June 30, 2021 | 0.1201 |
| March 31, 2021 | 0.1332 |
| December 31, 2020 | 0.2674 |
| September 30, 2020 | 0.3061 |
| June 30, 2020 | 0.3993 |
| March 31, 2020 | 0.3428 |
| December 31, 2019 | 0.3866 |
| September 30, 2019 | 0.33 |
| June 30, 2019 | 0.3137 |
| March 31, 2019 | -1.587 |
| December 31, 2018 | 0.2922 |
| September 30, 2018 | 0.2424 |
| June 30, 2018 | 0.2353 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.2157 |
| December 31, 2017 | 0.1931 |
| September 30, 2017 | 0.187 |
| June 30, 2017 | 0.2195 |
| March 31, 2017 | 0.1032 |
| December 31, 2016 | 0.0973 |
| September 30, 2016 | 0.1064 |
| June 30, 2016 | 0.1686 |
| March 31, 2016 | 0.3084 |
| December 31, 2015 | -1.526 |
| September 30, 2015 | 0.2184 |
| June 30, 2015 | -0.1907 |
| March 31, 2015 | 13.70 |
| December 31, 2014 | -0.1046 |
| September 30, 2014 | -0.0574 |
| June 30, 2014 | -0.0485 |
| March 31, 2014 | -0.0484 |
| December 31, 2013 | -1.984 |
| September 30, 2013 | -1.669 |
| June 30, 2013 | -0.6234 |
| March 31, 2013 | -0.4602 |
| December 31, 2012 | -0.315 |
| September 30, 2012 | -0.0095 |
| June 30, 2012 | -0.0004 |
| March 31, 2012 | -0.2268 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0691
Minimum
Mar 2022
0.5897
Maximum
Sep 2022
0.255
Average
0.1696
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Biomarin Pharmaceutical Inc | 0.1098 |
| BioCardia Inc | 0.00 |
| Zevra Therapeutics Inc | 1.796 |
| Verrica Pharmaceuticals Inc | -3.214 |
| Terns Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 87.85M |
| Total Liabilities (Quarterly) | 29.60M |
| Shareholders Equity (Quarterly) | 58.25M |
| Current Ratio | 3.080 |
| Net Debt Paydown Yield | -0.36% |